133 related articles for article (PubMed ID: 10417612)
1. Mitigation of delayed-type hypersensitivity reactions by a CD44 variant isoform v3-specific antibody: blockade of leukocyte egress.
Seiter S; Engel P; Föhr N; Zöller M
J Invest Dermatol; 1999 Jul; 113(1):11-21. PubMed ID: 10417612
[TBL] [Abstract][Full Text] [Related]
2. The CD44 variant isoforms CD44v6 and CD44v7 are expressed by distinct leukocyte subpopulations and exert non-overlapping functional activities.
Seiter S; Schmidt DS; Zöller M
Int Immunol; 2000 Jan; 12(1):37-49. PubMed ID: 10607748
[TBL] [Abstract][Full Text] [Related]
3. Anti-CD44-mediated blockade of leukocyte migration in skin-associated immune diseases.
Zöller M; Gupta P; Marhaba R; Vitacolonna M; Freyschmidt-Paul P
J Leukoc Biol; 2007 Jul; 82(1):57-71. PubMed ID: 17442857
[TBL] [Abstract][Full Text] [Related]
4. Chronic delayed-type hypersensitivity reaction as a means to treat alopecia areata.
Zöller M; Freyschmidt-Paul P; Vitacolonna M; McElwee KJ; Hummel S; Hoffmann R
Clin Exp Immunol; 2004 Mar; 135(3):398-408. PubMed ID: 15008971
[TBL] [Abstract][Full Text] [Related]
5. CD44 variant isoform expression in a variety of skin-associated autoimmune diseases.
Seiter S; Schadendorf D; Tilgen W; Zöller M
Clin Immunol Immunopathol; 1998 Oct; 89(1):79-93. PubMed ID: 9756727
[TBL] [Abstract][Full Text] [Related]
6. CD44v10 expression in the mouse and functional activity in delayed type hypersensitivity.
Rösel M; Seiter S; Zöller M
J Cell Physiol; 1997 Jun; 171(3):305-17. PubMed ID: 9180900
[TBL] [Abstract][Full Text] [Related]
7. Curative treatment of an experimentally induced colitis by a CD44 variant V7-specific antibody.
Wittig B; Schwärzler C; Föhr N; Günthert U; Zöller M
J Immunol; 1998 Aug; 161(3):1069-73. PubMed ID: 9686562
[TBL] [Abstract][Full Text] [Related]
8. Treatment with an anti-CD44v10-specific antibody inhibits the onset of alopecia areata in C3H/HeJ mice.
Freyschmidt-Paul P; Seiter S; Zöller M; König A; Ziegler A; Sundberg JP; Happle R; Hoffmann R
J Invest Dermatol; 2000 Oct; 115(4):653-7. PubMed ID: 10998138
[TBL] [Abstract][Full Text] [Related]
9. CD44 is critical for airway accumulation of antigen-specific Th2, but not Th1, cells induced by antigen challenge in mice.
Katoh S; Kaminuma O; Hiroi T; Mori A; Ohtomo T; Maeda S; Shimizu H; Obase Y; Oka M
Eur J Immunol; 2011 Nov; 41(11):3198-207. PubMed ID: 21874648
[TBL] [Abstract][Full Text] [Related]
10. Short-term treatment with anti-CD44v7 antibody, but not CD44v4, restores the gut mucosa in established chronic dextran sulphate sodium (DSS)-induced colitis in mice.
Farkas S; Hornung M; Sattler C; Anthuber M; Gunthert U; Herfarth H; Schlitt HJ; Geissler EK; Wittig BM
Clin Exp Immunol; 2005 Nov; 142(2):260-7. PubMed ID: 16232212
[TBL] [Abstract][Full Text] [Related]
11. Distinct CD44 splice variants differentially affect collateral artery growth.
Bot PT; Grundmann S; van Royen N; Joosten SP; Schirmer SH; de Kleijn DP; Pals ST; Pasterkamp G; Piek JJ; Hoefer IE
Curr Vasc Pharmacol; 2013 Jan; 11(1):13-20. PubMed ID: 23391418
[TBL] [Abstract][Full Text] [Related]
12. Exposure to T helper 2 cytokines in vivo before encounter with antigen selects for T helper subsets via alterations in antigen-presenting cell function.
Cua DJ; Coffman RL; Stohlman SA
J Immunol; 1996 Oct; 157(7):2830-6. PubMed ID: 8816386
[TBL] [Abstract][Full Text] [Related]
13. Transient CD44 variant isoform expression and reduction in CD4(+)/CD25(+) regulatory T cells in C3H/HeJ mice with alopecia areata.
Zöller M; McElwee KJ; Engel P; Hoffmann R
J Invest Dermatol; 2002 Jun; 118(6):983-92. PubMed ID: 12060392
[TBL] [Abstract][Full Text] [Related]
14. Reduced expression of CD44v3 variant isoform is associated with unfavorable outcome in non-small cell lung carcinoma.
Pirinen R; Hirvikoski P; Böhm J; Kellokoski J; Moisio K; Virén M; Johansson R; Hollmén S; Kosma VM
Hum Pathol; 2000 Sep; 31(9):1088-95. PubMed ID: 11014576
[TBL] [Abstract][Full Text] [Related]
15. CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells.
Bourguignon LY; Gunja-Smith Z; Iida N; Zhu HB; Young LJ; Muller WJ; Cardiff RD
J Cell Physiol; 1998 Jul; 176(1):206-15. PubMed ID: 9618160
[TBL] [Abstract][Full Text] [Related]
16. CD44 variant isoforms on blood leukocytes in chronic inflammatory bowel disease and other systemic autoimmune diseases.
Wittig B; Seiter S; Schmidt DS; Zuber M; Neurath M; Zöller M
Lab Invest; 1999 Jun; 79(6):747-59. PubMed ID: 10378517
[TBL] [Abstract][Full Text] [Related]
17. Murine lymph node antigen presenting cells are the main source of interleukin-6 in the initiation of delayed-type hypersensitivity.
Ulrich P; Vohr HW
Eur Cytokine Netw; 1996 Sep; 7(3):401-7. PubMed ID: 8954184
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronan-independent adhesion of CD44H+ and CD44v10+ lymphocytes to dermal microvascular endothelial cells and keratinocytes.
Weimann TK; Wagner C; Funk R; Hirche H; Goos M; Wagner SN
J Invest Dermatol; 2001 Oct; 117(4):949-57. PubMed ID: 11676837
[TBL] [Abstract][Full Text] [Related]
19. Transplant tolerance associated with a Th1 response and not broken by IL-4, IL-5, and TGF-beta blockade or Th1 cytokine administration.
Plain KM; Boyd R; Verma ND; Robinson CM; Tran GT; Hodgkinson SJ; Hall BM
Transplantation; 2007 Mar; 83(6):764-73. PubMed ID: 17414711
[TBL] [Abstract][Full Text] [Related]
20. Reduced contact sensitivity reactions in mice treated with monoclonal antibodies to leukocyte function-associated molecule-1 and intercellular adhesion molecule-1.
Scheynius A; Camp RL; Puré E
J Immunol; 1993 Jan; 150(2):655-63. PubMed ID: 8093459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
